Emcure
Emcure Pharmaceuticals Ltd., a prominent player in the Indian pharmaceutical industry, is headquartered in Pune, India. Founded in 1981, the company has established a strong presence in various operational regions, including Asia, Africa, and the Americas. Emcure focuses on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and biosimilars. With a commitment to quality and innovation, Emcure has achieved significant milestones, such as receiving multiple international certifications and expanding its product portfolio to over 300 brands. The company is particularly noted for its expertise in oncology, cardiology, and anti-infectives, setting it apart in a competitive market. Emcure's dedication to research and development has solidified its position as a trusted name in healthcare, contributing to improved patient outcomes globally.
DitchCarbon Score
How does Emcure's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Emcure's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Emcure's reported carbon emissions
Emcure Pharmaceuticals, headquartered in India, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments under frameworks such as the Science Based Targets initiative (SBTi). Without specific emissions data or reduction initiatives, it is unclear how Emcure is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The absence of reported emissions and targets suggests a potential area for improvement in transparency and commitment to sustainability practices.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Emcure is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
